about
Borderline personality disorder and childhood trauma: exploring the affected biological systems and mechanismsLong-acting antipsychotic drugs for the treatment of schizophrenia: use in daily practice from naturalistic observations.Brain anatomy of persistent violent offenders: more rather than less.Medial temporal atrophy but not memory deficit predicts progression to dementia in patients with mild cognitive impairment.Depression prevention and mental health promotion interventions: is stigma taken into account? An overview of the Italian initiatives.Voxel-based morphometry study on monozygotic twins discordant for Alzheimer's disease.Abnormal hippocampal shape in offenders with psychopathy.Alexithymia in healthy women: a brain morphology study.Structural brain features of borderline personality and bipolar disorders.Effects of cognitive remediation therapy on neurocognition and negative symptoms in schizophrenia: an Italian naturalistic study.Development and Validation of the Health of the Nation Outcome Scales-Residential Facility (HoNOS-RF).Clinical and neuropsychological features associated with structural imaging patterns in patients with mild cognitive impairment.MRI of hippocampus and entorhinal cortex in mild cognitive impairment: a follow-up study.Volumetric and topographic differences in hippocampal subdivisions in borderline personality and bipolar disorders.Topographic correspondence between white matter hyperintensities and brain atrophy.Validation study of the three-objects-three-places test: a screening test for Alzheimer's disease.Association between subcortical vascular disease on CT and neuropathological findings.A comparison between the accuracy of voxel-based morphometry and hippocampal volumetry in Alzheimer's disease.Subcortical vascular lesions predict functional recovery after rehabilitation in patients with L-dopa refractory parkinsonism.Pathological validation of a CT-based scale for subcortical vascular disease. The OPTIMA Study.Frontotemporal dementia as a neural system diseaseEmotion regulation in Schizophrenia: A comparison between implicit (EEG and fNIRS) and explicit (valence) measures: Preliminary observationsErratum to: Long-acting antipsychotic drugs for the treatment of schizophrenia: use in daily practice from naturalistic observationsA Clinical Trial of a Psychoeducation Group Intervention for Patients With Borderline Personality DisorderThe brief assessment of cognition in affective disorders: Normative data for the Italian population
P50
Q33805362-E6571B3B-AEE6-4684-B87E-4C08C07B20ECQ34386881-84225788-F8C3-4BA9-99F1-1EFD1F5B45F6Q34802033-FBE76DCE-22E4-4AEA-B564-5DB3660A86F7Q36141850-D5A09753-BE94-4380-9110-5A910529BCCDQ38085091-15EC7DE2-EE74-45B0-BEE3-10B95D7FA15DQ41359957-B8C84F56-FDE4-412A-A682-0D683C2903D5Q43283432-481FC621-A25B-4D7A-8E3D-9127B95BE9E6Q43640878-14C4E120-DFA7-472D-9947-44E1FE5B60F4Q44692300-8D73CB7F-6930-46B4-B3E8-2572D5D7D8AAQ46007023-1F088E60-0EBE-4D1B-854B-CAA442D80989Q47605984-077F1EA2-FD57-4465-AA74-0FAA989948BBQ48311450-F6C8A8C9-382B-424E-B059-8B622ED19B23Q48373565-32DA619A-A135-4ECF-A426-5766AD70B288Q48390146-D017539A-B4E9-4938-B483-FF39491BE4E7Q48636682-0ECB41DE-888E-4B50-9EC6-69E0B8F3932AQ51721044-9CDBCD6A-78F9-41CA-8A2B-CAD00A844244Q51939212-AEA76F78-C4EC-4292-A719-F9FD547E5354Q51942911-731E84A3-0B38-465A-9C83-C2CAFD9AF71FQ51944022-94E92ADF-78A3-453E-8523-58D1EE15197CQ51983200-38DEBAEA-C1EC-4067-99C4-00AF6D8B9273Q57741732-0A4AED84-1048-437D-AA62-3DEE320912D4Q60050883-11A120B3-FA88-415F-BB55-C24AD1366D16Q60050885-500936AA-651B-4E74-92F5-D68D4B4CF3D3Q92518725-2A59000A-11AE-4438-BDCC-6E214B5A2512Q93130572-26B04AE2-8F76-4048-8427-500B3F4BFD73
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Roberta Rossi
@ast
Roberta Rossi
@en
Roberta Rossi
@es
Roberta Rossi
@nl
Roberta Rossi
@sl
type
label
Roberta Rossi
@ast
Roberta Rossi
@en
Roberta Rossi
@es
Roberta Rossi
@nl
Roberta Rossi
@sl
prefLabel
Roberta Rossi
@ast
Roberta Rossi
@en
Roberta Rossi
@es
Roberta Rossi
@nl
Roberta Rossi
@sl
P106
P1153
12767248900
P21
P31
P496
0000-0001-8408-1124